Helen Heslop, MD, DSc (Hon)
Disclosures: Ownership Interest-ViraCyte|Consulting Fee-Novartis AG|Ownership Interest-Marker Therapeutics|Consulting Fee-Gilead|Consulting Fee-Cytosen|Contracted Research-Cell Medica|Contracted Research-Tessa Therapeutics
No Bio Available.